Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

646 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of long-acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084.
Delany-Moretlwe S, Hanscom B, Guo X, Nkabiito C, Mandima P, Nahirya PN, Mpendo J, Bhondai-Mhuri M, Mgodi N, Berhanu R, Farrior J, Piwowar-Manning E, Ford SL, Hendrix CW, Rinehart AR, Rooney JF, Adeyeye A, Landovitz RJ, Cohen MS, Hosseinipour MC, Marzinke MA; HPTN 084 Study Team. Delany-Moretlwe S, et al. Among authors: rooney jf. J Int AIDS Soc. 2025 Jan;28(1):e26401. doi: 10.1002/jia2.26401. J Int AIDS Soc. 2025. PMID: 39748218 Free PMC article. Clinical Trial.
Tenofovir Disoproxil Fumarate/Emtricitabine Prophylaxis Has No Effect on Bone Mineral Density and Bone Mineral Content in African Breastfeeding Women Receiving Pre-Exposure Prophylaxis for HIV.
Kistan G, Sebitloane M, Lombard C, Godlwana Z, Desmond AC, Clark R, Rooney JF, Gray G, Moodley D. Kistan G, et al. Among authors: rooney jf. J Acquir Immune Defic Syndr. 2024 Nov 27. doi: 10.1097/QAI.0000000000003563. Online ahead of print. J Acquir Immune Defic Syndr. 2024. PMID: 39593198
Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial STIs: A Secondary Analysis of HPTN 083.
Clement ME, Hanscom B, Haines D, Bazan JA, Chotirosniramit N, Kofron R, Mannheimer S, Mayer KH, Torres Silva MS, Soto-Torres L, Rinehart AR, Rooney JF, Jennings A, Gomez-Feliciano K, McCauley M, Grinsztejn B, Landovitz RJ; for HPTN 083 Study Team. Clement ME, et al. Among authors: rooney jf. Clin Infect Dis. 2024 Nov 23:ciae572. doi: 10.1093/cid/ciae572. Online ahead of print. Clin Infect Dis. 2024. PMID: 39579334
Bioinformatic Workflows for Deriving Transcriptomic Points of Departure: Current status, Data Gaps, and Research Priorities.
O'Brien J, Mitchell C, Auerbach S, Doonan L, Ewald J, Everett L, Faranda A, Johnson K, Reardon A, Rooney J, Shao K, Stainforth R, Wheeler M, Dalmas Wilk D, Williams A, Yauk C, Costa E. O'Brien J, et al. Among authors: rooney j. Toxicol Sci. 2024 Nov 5:kfae145. doi: 10.1093/toxsci/kfae145. Online ahead of print. Toxicol Sci. 2024. PMID: 39499193
HIV DNA Levels in Persons Who Acquired HIV in the Setting of Long-Acting Cabotegravir for HIV Prevention: Analysis of Cases from HPTN 083 and 084.
Fogel JM, Persaud D, Piwowar-Manning E, Richardson P, Szewczyk J, Marzinke MA, Wang Z, Guo X, McCauley M, Farrior J, Tran HV, Ungsedhapand C, Mathew CA, Mpendo J, Rinehart AR, Rooney JF, Cohen MS, Hanscom B, Grinsztejn B, Hosseinipour MC, Delany-Moretlwe S, Landovitz RJ, Eshleman SH; HPTN 083 and HPTN 084 Study Teams. Fogel JM, et al. Among authors: rooney jf. AIDS Res Hum Retroviruses. 2025 Jan;41(1):30-36. doi: 10.1089/aid.2024.0049. Epub 2024 Oct 28. AIDS Res Hum Retroviruses. 2025. PMID: 39466048
Pharmacologic evaluation of delayed long-acting cabotegravir administration among cisgender women in HPTN 084.
Marzinke MA, Han K, Hanscom B, Guo X, Piwowar-Manning E, Hendrix CW, Rose S, Spooner E, Mathew C, Innes S, Sekabira R, Mutambanengwe M, Rooney JF, Rinehart AR, Adeyeye A, Cohen MS, Hosseinipour M, Ford SL, Delany-Moretlwe S. Marzinke MA, et al. Among authors: rooney jf. Antimicrob Agents Chemother. 2024 Nov 6;68(11):e0099424. doi: 10.1128/aac.00994-24. Epub 2024 Sep 23. Antimicrob Agents Chemother. 2024. PMID: 39311597 Clinical Trial.
A randomized, placebo-controlled, dose-escalation phase I/II multicenter trial of low-dose cidofovir for BK polyomavirus nephropathy.
Imlay H, Gnann JW Jr, Rooney J, Peddi VR, Wiseman AC, Josephson MA, Kew C, Young JH, Adey DB, Samaniego-Picota M, Whitley RJ, Limaye AP. Imlay H, et al. Among authors: rooney j. Transpl Infect Dis. 2024 Dec;26(6):e14367. doi: 10.1111/tid.14367. Epub 2024 Sep 3. Transpl Infect Dis. 2024. PMID: 39226143 Free PMC article. Clinical Trial.
646 results